NRx Pharmaceuticals, Inc. (NRXP )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NRXP
- Company NRx Pharmaceuticals, Inc.
- Price $3.87
- Changes Percentage -10.62
- Change -0.46
- Day Low $3.65
- Day High $4.4
- Year High $5.06
- Year Low $1.62
- Market Cap $70,007,142
- Price Avg 50 EMA (D) $2.91
- Price Avg 200 EMA (D) $2.58
- Exchange NASDAQ
- Volume 4,556,041
- Average Volume 1,135,248
- Open $4.36
- Previous Close $4.33
- EPS -1.04
- PE -3.89
- Earnings Announcement 2026-08-14 12:30:00
- Shares Outstanding $17,285,714
Company brief: NRX PHARMACEUTICALS, INC. (NRXP )
- Healthcare
- Biotechnology
- Mr. Stephen H. Willard Esq.
- https://www.nrxpharma.com
- US
- N/A
- 12-04-2017
- US6294441000
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.